Highlight
- Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) post-primary treatment for advanced epithelial ovarian cancer (EOC) is feasible and safe.
- No conversions to laparotomy or serious perioperative complications occurred, highlighting minimally invasive benefits.
- Grade 3/4 adverse events were limited to temporary myelosuppression, resolving within six weeks.
- Patient-reported quality of life improved post-procedure, supporting tolerability of consolidation laparoscopic HIPEC.
Study Background
Specialty calculators
For clinical reference; use professional judgment.
